Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins.

Drug Delivery
Giuseppina IoeleG Ragno

Abstract

Nowadays, an exciting challenge in the drug chemistry and technology research is represented by the development of methods aimed to protect molecular integrity and therapeutic activity of drugs from effects of light. The photostability characterization is ruled by ICH (The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), which releases details throughout basic protocols of stability tests to be performed on new medicinal products for human use. The definition of suitable photoprotective systems is fundamental for pharmaceutical manufacturing and for human healthy as well, since light exposure may affect either drugs or drug formulations giving rise even to allergenic or mutagenic by-products. Here, we summarize and discuss the recent studies on the formulation of photosensitive drugs into supramolecular systems, capable of entrapping the molecules in a hollow of their structure by weak noncovalent interactions and protecting them from light. The best known supramolecular matrices belong to the 'auto-assembled' structures, of which liposomes are the most representative, and the 'host-guest' systems, of which cyclodextrins represent the most common 'host' counterpart. A relevan...Continue Reading

References

Jun 1, 1979·Photochemistry and Photobiology·P S Song, K J Tapley
Aug 1, 1991·Journal of Photochemistry and Photobiology. B, Biology·G M Beijersbergen van Henegouwen
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·P CrosassoL Cattel
May 5, 2000·International Journal of Pharmaceutics·M Brisaert, J Plaizier-Vercammen
Jul 27, 2000·Photochemistry and Photobiology·R H BisbyC G Morgan
Feb 13, 2001·International Journal of Pharmaceutics·T LoftssonE Stefánsson
Feb 24, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·K K VermaU Banerjee
May 5, 2001·International Journal of Pharmaceutics·Z PavelićR Schubert
Jul 27, 2001·Current Opinion in Chemical Biology·O Pillai, R Panchagnula
Aug 8, 2001·International Journal of Pharmaceutics·H H Tønnesen
Oct 16, 2001·Journal of Pharmaceutical and Biomedical Analysis·M BrisaertJ Plaizier-Vercammen
Mar 1, 2002·Toxicology in Vitro : an International Journal Published in Association with BIBRA·R S RayR K Hans
May 7, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Leila Zarif
Aug 15, 2002·International Journal of Pharmaceutics·Mohsen A BayomiAbdulaziz A Al-Angary
Apr 8, 2003·Current Protein & Peptide Science·V P Torchilin, T S Levchenko
Jul 5, 2003·International Journal of Pharmaceutics·Maria ManconiAnna M Fadda
Oct 3, 2003·International Journal of Pharmaceutics·G RagnoA Spagnoletta
Apr 6, 2004·Journal of Pharmaceutical and Biomedical Analysis·R PomponioF Maestrelli
Apr 6, 2004·Journal of Pharmaceutical and Biomedical Analysis·S TommasiniR Ficarra
Sep 29, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Wenzhan Yang, Melgardt M de Villiers
Nov 30, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maria Laura ImmordinoLuigi Cattel
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hakon H SigurdssonThorsteinn Loftsson
Jan 25, 2005·International Journal of Pharmaceutics·Fu-gen GuYong-liang Gao
Jan 29, 2005·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·M Ahmed, S N Goldberg
Feb 19, 2005·Seminars in Oncology·Theresa M Allen, Francis J Martin
Mar 22, 2005·International Journal of Pharmaceutics·G IoeleG Ragno
Apr 28, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·K L YapP C Ho
Jul 19, 2005·International Journal of Pharmaceutics·Zeljka PavelićIvan Jalsenjak
Aug 12, 2005·Drug Development and Industrial Pharmacy·Meiying NingZhongwei Gu
Sep 16, 2005·The Science of the Total Environment·Marina IsidoriMaria Rubino
Oct 6, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Luana PerioliCarlo Rossi
Oct 26, 2005·Journal of Pharmaceutical and Biomedical Analysis·Rosanna TursilliSanto Scalia
Nov 22, 2005·Expert Opinion on Drug Delivery·Xiaogang Pan, Robert J Lee
Nov 29, 2005·Advanced Drug Delivery Reviews·Khuloud T Al-JamalAlexander T Florence
Dec 16, 2005·AAPS PharmSciTech·Rajeswari ChallaR K Khar
Dec 31, 2005·Pharmaceutical Research·Takahiro GotoKozo Takayama
Jan 13, 2006·Journal of Pharmaceutical and Biomedical Analysis·Gaetano RagnoAntonella Risoli
Feb 4, 2006·International Journal of Pharmaceutics·Géraldine PielLuc Delattre
Feb 4, 2006·Analytical and Bioanalytical Chemistry·Suzanne J BosUwe Karst
May 10, 2006·Mycoses·Mohamed A A KassemMohamed H M El-Komy
May 23, 2006·International Journal of Pharmaceutics·Santo ScaliaValentina Iannuccelli

❮ Previous
Next ❯

Citations

Mar 22, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michal HricovíniVlasta Brezová
May 8, 2020·Nucleic Acid Therapeutics·Jale MuslehiddinogluDoug P Nesta
Jul 4, 2020·Chemical Communications : Chem Comm·Laís RibovskiInge S Zuhorn
May 23, 2020·Drug Delivery and Translational Research·Ana Cláudia SantosFrancisco Veiga
Nov 18, 2018·Chemical Communications : Chem Comm·Weiwei FengZhichao Pei
Dec 22, 2019·Pharmaceutics·Agata Kryczyk-PoprawaWłodzimierz Opoka
Oct 29, 2020·Physical Chemistry Chemical Physics : PCCP·Sharmistha Dutta Choudhury, Haridas Pal
May 8, 2020·International Journal of Pharmaceutics·Zhiqiang WangFrançois-Xavier Legrand

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.